CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. scores highest on Nitro (52) and lowest on Anchor (32). Its PosiPenta is 42.57 out of 100, around the middle of similar companies.
On the Penta Grid this week, CNS Pharmaceuticals, Inc. is Grid #451 of 837 in the Healthcare sector in United States, and Grid #2,637 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | 42.57 | 47 | 41 | 52 | 41 | 32 |
| Imunon, Inc. | 25.70 | 31 | 39 | 19 | 9 | 30 |
| Aprea Therapeutics, Inc. | 47.60 | 49 | 56 | 28 | 70 | 36 |
| XWELL, Inc. | 28.18 | 0 | 35 | 41 | 15 | 50 |
| ENDRA Life Sciences Inc. | 42.34 | 38 | 35 | 67 | 38 | 34 |
| Skye Bioscience, Inc. | 20.83 | 0 | 25 | 11 | 43 | 26 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.27 |
| P/B ratio | 0.39 |
EEarnings
| Trailing EPS | ₹-1695.40 |
| Forward EPS | ₹-36.94 |
NNitro
| Price | 459.46 |
| 52-week high | 998.30 |
| 52-week low | 179.96 |
| Fall from 52-week high | 54.0% |
TTorque
| Return on equity (ROE) | -106.62% |
| Debt-to-equity | 0.07 |
AAnchor
| Beta (price swings) | 1.02 |
| Market cap | ₹67 Cr |
| Insider holding | 0.95% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is CNS Pharmaceuticals, Inc.'s PosiPenta score?
CNS Pharmaceuticals, Inc.'s PosiPenta is 42.57 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does CNS Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, CNS Pharmaceuticals, Inc. is Grid #451 of 837 in the Healthcare sector in United States, and Grid #2,637 of 4,000 in United States.
Which PosiPenta pillar is strongest for CNS Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 52 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for CNS Pharmaceuticals, Inc.?
Anchor (stability and dividends), with a score of 32 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.